Whole-genome analysis of an aggressive metastatic pancreatic solid pseudopapillary neoplasm

Pancreatic solid pseudopapillary neoplasms (SPNs) are uncommon tumors that rarely exhibit aggressive behavior. Given disease rarity, comprehensive studies to understand tumor biology, clinical course, and optimal management are limited. We describe an unusual case of a 55-year-old man with metastatic pancreatic SPN, where whole-genome and transcriptome analyses of the primary tumor and a metastatic liver lesion revealed a shared homozygous non-canonical mutation in APC. The patient received upfront modified FOLFIRINOX (infusional 5-fluorouracil, irinotecan, and oxaliplatin) chemotherapy due to rapidly progressive symptoms, demonstrating an early and sustained treatment response. Therefore, we identified potential genetic determinants of tumorigenesis and progression in a pathologically and clinically aggressive SPN, which may have important prognostic and treatment implications.

Authors

Institutions

Publication Details

Journal
npj Precision Oncology
Published
2025-03-04
DOI
https://doi.org/10.1038/s41698-025-00843-7
Citations
4
Primary Topic
Pancreatic and Hepatic Oncology Research
Type
article
Field-Weighted Citation Impact
4.18
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Whole-genome analysis of an aggressive metastatic pancreatic solid pseudopapillary neoplasm

Ayman Aldeheshi, Daniel J. Renouf, Erin Pleasance, Jessica Nelson et al.
4 citations
npj Precision Oncology
Pancreatic and Hepatic Oncology Research
4.18
article

Whole-genome analysis of an aggressive metastatic pancreatic solid pseudopapillary neoplasm

Ayman Aldeheshi, Daniel J. Renouf, Erin Pleasance, Jessica Nelson, Phoebe T. M. Cheng, Melissa K. McConechy, Marco A. Marra, J. Paul Taylor, James T. Topham, Janessa Laskin, Steven J.M. Jones, David F. Schaeffer
article en
4 citations

Abstract

Pancreatic solid pseudopapillary neoplasms (SPNs) are uncommon tumors that rarely exhibit aggressive behavior. Given disease rarity, comprehensive studies to understand tumor biology, clinical course, and optimal management are limited. We describe an unusual case of a 55-year-old man with metastatic pancreatic SPN, where whole-genome and transcriptome analyses of the primary tumor and a metastatic liver lesion revealed a shared homozygous non-canonical mutation in APC. The patient received upfront modified FOLFIRINOX (infusional 5-fluorouracil, irinotecan, and oxaliplatin) chemotherapy due to rapidly progressive symptoms, demonstrating an early and sustained treatment response. Therefore, we identified potential genetic determinants of tumorigenesis and progression in a pathologically and clinically aggressive SPN, which may have important prognostic and treatment implications.

npj Precision OncologyVol. 9(1)
BC Cancer Agency (CA), University of British Columbia (CA), Canada's Michael Smith Genome Sciences Centre (CA), Pancreas Centre (Canada) (CA)
Zero hunger
Openalex Percentile: Top 6%
Pancreatic and Hepatic Oncology Research
4.18
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Whole-genome analysis of an aggressive metastatic pancreatic solid pseudopapillary neoplasm — Ayman Aldeheshi, Daniel J. Renouf, et al. · npj Precision Oncology (2025) | TGRS Research Map | TGRS